Five Things To Know From Moderna’s Analyst Day

 
• By Joseph Haas
  
mRNA
Moderna outlined plans to return to growth in 2026 and reach break-even in 2028 • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business